Dorsal Scapular Nerve Injection Combined With Muscle Needle Release

Efficacy of Ultrasound-guided Dorsal Scapular Nerve Injection Combined With Rhomboideus Muscle Needle Release

Status

Not yet recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06329960

Enrollment

Registered

2024-03-26

Start date

2024-05-01

Completion date

2024-11-30

Last updated

2024-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dorsal Scapular Nerve Entrapment

Brief summary

Ultrasound-guided perineural injection (PIT) of 5% dextrose (D5W) hydrodissection has been widely used in the treatment of peripheral entrapment neuropathies. However, there are few studies investigating the efficacy of PIT using D5W HD for dorsal scapular nerve (DSN) entrapment. Generally, the DSN entrapment causes the stiffness of the major and minor rhomboideus(2). In clinical practice, the investigators observed that ultrasound-guided PIT using D5W HD combined with needle release of major and minor rhomboideus significantly relieved the pain of scapular region. Therefore, the investigators aimed to evaluate the 6-month efficacy of this procedure for the participants with DSN entrapment.

Interventions

OTHERUltrasound-guided injection combined with needle release

Ultrasound-guided PIT using D5W HD for dorsal scapular nerve combined with needle release of major and minor rhomboideus

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patients with DSN entrapment confirmed by electrophysiological study; * age 18-80 years; * patients who were irresponsive to conservative treatment; * symptoms persisted for more than 3 months.

Exclusion criteria

* pregnancy * DSN entrapment caused by trauma, surgery or occupying lesions of DSN; * concurrent presence of rheumatic immune diseases, hypothyroidism, or diabetes mellitus; * C5/6 lumbar radiculopathy; * previous history of local injection or surgery for DSN entrapment.

Design outcomes

Primary

Measure	Time frame	Description
visual analogue scale (VAS)	before treatment, as well as 1, 3, 6 months post treatment	VAS is the most common tool to evaluate discomfort for patients with peripheral entrapment neuropathies, with scores ranging from 0 (no pain) to 10 (intolerant pain)

Countries

China

Contacts

Primary ContactJiaan Zhu, PhD

canzhujia@126.com+86-010-88325378

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026